Cannabics Pharmaceuticals Investors

Cannabics Pharmaceuticals Inc. (OTCQB: CNBX) is a U.S. public company and a global leader in the development of cancer related cannabinoid-based medicine. The Company’s R&D is based in Israel, where it is licensed by the Ministry of Health to conduct scientific and clinical research on cannabinoid formulations and cancer.

Last Funding Type: Undisclosed
Total Funding: 3000000 USD
Last Funding Date: 2017-05-06
Funding Status: IPO
Number Of Exists: 1
Employee Number: 1-10
Estimated Revenue: Less than $1M
Founded Date: 2012-03-21
Headquarters: Bethesda, Maryland, United States
Industry: Biotechnology, Health Care, Science and Engineering
Investor Type: Not Classified